Dr. Akin is board certified in Reproductive Endocrinology and Infertility as well as Obstetrics & Gynecology by the American Board of Obstetrics & Gynecology. He founded Bluegrass Fertility Center in 2003 and serves as the medical director of the fertility center. Bluegrass Fertility Center, located in the heart of Lexington, Kentucky offers the latest advances in Assisted Reproductive Technology (ART).

Dr. Akin and our highly trained staff specialize in providing the latest technology diagnostic testing and advanced infertility treatment.

Facebook profile

Update Share

Our Services

Report

Bluegrass Fertility Center, located in the heart of Lexington, Kentucky offers the latest advances in Assisted Reproductive Technology (ART). Dr. James Akin and our highly trained staff specialize in providing the latest technology diagnostic testing and advanced infertility treatment. We look forward to helping you achieve your dreams.

Donor Egg Program

Report

Women are candidates for an egg donor in vitro fertilization (IVF) cycle if they are in good health and less than 50 years old. Women needing egg donation include those who have advanced maternal age, premature menopause, premature ovarian failure, surgically removed ovaries, prior poor response with own eggs through IVF and genetic diseases which would be passed on to offspring.

Egg Freezing

Report

Description of Procedure: Until recently, pregnancy success rates from egg freezing procedures were very poor. Scientific advances have now made egg freezing a viable option for women. Eggs can now be successfully frozen, stored and thawed for use at a later date. However, not all eggs freeze and thaw well.

Intrauterine Insemination - IUI

Report

Clomiphene citrate is commonly used along with intrauterine insemination as a fertility treatment. Clomiphene citrate is the generic name of a fertility pill which is used to induce ovulation. Brand names include Clomid and Serophene. This medication is associated with an 8% risk of twinning (normal risk is 1%) and about 1/1000 risk of triplets or more.

Be the first to review Akin James.

Write a Review